HARBOURVEST PARTNERS LLC - Q2 2016 holdings

$270 Million is the total value of HARBOURVEST PARTNERS LLC's 21 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 60.9% .

 Value Shares↓ Weighting
W SellWayfair, Inc.$147,336,000
-14.5%
3,777,834
-5.3%
71.06%
-3.6%
CDW NewCDW Corp.$30,393,000758,318
+100.0%
14.66%
FNJN  Finjan Holdings, Inc.$7,832,000
+100.0%
4,303,4350.0%3.78%
+125.6%
LC BuyLendingClub Corp.$5,110,000
-41.9%
1,188,434
+12.2%
2.46%
-34.4%
SAGE  Sage Therapeutics, Inc.$3,151,000
-6.0%
104,5680.0%1.52%
+6.1%
TRVN BuyTrevena, Inc.$2,366,000
+2050.9%
375,559
+2731.4%
1.14%
+2327.7%
FIVN NewFive9, inc.$2,246,000188,777
+100.0%
1.08%
SCTY  SolarCity Corporation$1,573,000
-2.7%
65,7540.0%0.76%
+9.8%
ETSY  ETSY, Inc.$1,245,000
+10.3%
129,8190.0%0.60%
+24.2%
FMI  Foundation Medical, Inc.$1,056,000
+2.7%
56,5670.0%0.51%
+15.9%
NTRA NewNatera, Inc.$1,054,00087,418
+100.0%
0.51%
ZLTQ  Zeltiq Aesthetics, Inc.$925,000
+0.5%
33,8620.0%0.45%
+13.5%
ZFGN  Zafgen, Inc.$670,000
-10.3%
111,8940.0%0.32%
+1.3%
BOX  Box, Inc.$604,000
-15.6%
58,3690.0%0.29%
-4.9%
MESG  Xura, Inc.$433,000
+24.1%
17,7340.0%0.21%
+40.3%
RUN NewSunRun, Inc.$390,00063,800
+100.0%
0.19%
CARB NewCarbonite, Inc.$301,00030,941
+100.0%
0.14%
VRAY SellViewRay, Inc.$276,000
-66.4%
67,411
-64.7%
0.13%
-62.1%
ATRA  Atara Biotherapeutics, Inc.$237,000
+17.9%
10,5430.0%0.11%
+32.6%
CTMX NewCytomx, Inc.$102,00010,000
+100.0%
0.05%
CMLS  Cumulus Media, Inc.$35,000
-28.6%
113,8750.0%0.02%
-19.0%
MOBL ExitMobileIron, Inc.$0-11,122
-100.0%
-0.02%
MEET ExitMeetMe, Inc.$0-135,801
-100.0%
-0.16%
NSTG ExitNanoString Technologies, Inc.$0-27,992
-100.0%
-0.18%
TDOC ExitTelaDoc, Inc.$0-45,409
-100.0%
-0.19%
ZAYO ExitZayo Group Holdings, Inc.$0-56,099
-100.0%
-0.58%
SUPN ExitSupernus Pharmaceuticals, Inc.$0-103,192
-100.0%
-0.67%
NXPI ExitNXP Semiconductors NV$0-196,020
-100.0%
-6.79%
FIS ExitFidelity National Information Services, Inc.$0-278,951
-100.0%
-7.55%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wayfair, Inc.25Q3 202383.5%
Trevena, Inc.25Q4 20211.2%
Finjan Holdings, Inc.23Q2 202018.5%
Zuora, Inc.21Q3 20233.4%
Evelo Biosciences, Inc.20Q1 202326.3%
CytomX Therpeutics, Inc.19Q4 20212.3%
LendingClub Corp.18Q3 201911.9%
Rubius Therapeutics, Inc.18Q4 202221.4%
Solarwinds Corp.17Q4 202260.4%
Axcella Health, Inc.17Q2 20236.7%

View HARBOURVEST PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HARBOURVEST PARTNERS LLC Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SolarWinds CorpFebruary 14, 20223,719,6002.3%
N-able, Inc.December 20, 20213,719,6002.1%
OncoMed Pharmaceuticals IncFebruary 14, 20191,901,1064.9%
Wayfair Inc.February 16, 20162,115,2964.6%
ENVIVIO INCFebruary 13, 20133,639,93913.5%
NETWORK ENGINES INCSold outFebruary 13, 201300.0%
VOCALTEC COMMUNICATIONS LTDAugust 06, 2010243,6892.1%
CERAGON NETWORKS LTDSold outJuly 26, 200700.0%
VISTAPRINT LTDSold outFebruary 14, 200700.0%
VOCALTEC COMMUNICATIONS LTDMay 26, 20061,218,44424.4%

View HARBOURVEST PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
40-APP2024-04-24
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR/A2022-05-26
13F-HR2022-05-13

View HARBOURVEST PARTNERS LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (270337000.0 != 207335000.0)

Export HARBOURVEST PARTNERS LLC's holdings